BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23195224)

  • 1. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids.
    Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
    Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia Enhances Epithelial-Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids.
    Marín-Hernández Á; Gallardo-Pérez JC; Hernández-Reséndiz I; Del Mazo-Monsalvo I; Robledo-Cadena DX; Moreno-Sánchez R; Rodríguez-Enríquez S
    J Cell Physiol; 2017 Jun; 232(6):1346-1359. PubMed ID: 27661776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy Metabolism Drugs Block Triple Negative Breast Metastatic Cancer Cell Phenotype.
    Pacheco-Velázquez SC; Robledo-Cadena DX; Hernández-Reséndiz I; Gallardo-Pérez JC; Moreno-Sánchez R; Rodríguez-Enríquez S
    Mol Pharm; 2018 Jun; 15(6):2151-2164. PubMed ID: 29746779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy metabolism transition in multi-cellular human tumor spheroids.
    Rodríguez-Enríquez S; Gallardo-Pérez JC; Avilés-Salas A; Marín-Hernández A; Carreño-Fuentes L; Maldonado-Lagunas V; Moreno-Sánchez R
    J Cell Physiol; 2008 Jul; 216(1):189-97. PubMed ID: 18264981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
    Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
    Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids.
    Gallardo-Pérez JC; Rivero-Segura NA; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
    Biochim Biophys Acta; 2014 Jun; 1843(6):1043-53. PubMed ID: 24440856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
    De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
    Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma.
    Rodríguez-Enríquez S; Carreño-Fuentes L; Gallardo-Pérez JC; Saavedra E; Quezada H; Vega A; Marín-Hernández A; Olín-Sandoval V; Torres-Márquez ME; Moreno-Sánchez R
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1744-51. PubMed ID: 20654728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual regulation of energy metabolism by p53 in human cervix and breast cancer cells.
    Hernández-Reséndiz I; Román-Rosales A; García-Villa E; López-Macay A; Pineda E; Saavedra E; Gallardo-Pérez JC; Alvarez-Ríos E; Gariglio P; Moreno-Sánchez R; Rodríguez-Enríquez S
    Biochim Biophys Acta; 2015 Dec; 1853(12):3266-78. PubMed ID: 26434996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells.
    Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Marín-Hernández A; Ruiz-Azuara L; Moreno-Sánchez R
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):208-17. PubMed ID: 16580038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization.
    Hao W; Chang CP; Tsao CC; Xu J
    J Biol Chem; 2010 Apr; 285(17):12647-54. PubMed ID: 20110356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.
    Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Pavlides S; Tsirigos A; Ertel A; Pestell RG; Broda P; Minetti C; Lisanti MP; Sotgia F
    Cell Cycle; 2011 Dec; 10(23):4047-64. PubMed ID: 22134189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
    Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
    Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
    Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
    Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
    Gao C; Shen Y; Jin F; Miao Y; Qiu X
    PLoS One; 2016; 11(5):e0154576. PubMed ID: 27167619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.
    Zhang X; de Milito A; Olofsson MH; Gullbo J; D'Arcy P; Linder S
    Int J Mol Sci; 2015 Nov; 16(11):27313-26. PubMed ID: 26580606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
    Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53
    Hernández-Reséndiz I; Gallardo-Pérez JC; López-Macay A; Robledo-Cadena DX; García-Villa E; Gariglio P; Saavedra E; Moreno-Sánchez R; Rodríguez-Enríquez S
    J Cell Physiol; 2019 May; 234(5):5524-5536. PubMed ID: 30272821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the cell cycle via mitochondrial gene expression and energy metabolism in HeLa cells.
    Xiong W; Jiao Y; Huang W; Ma M; Yu M; Cui Q; Tan D
    Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):347-58. PubMed ID: 22343378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.